Form4insider filings, from the source

SEC Form 4 · accession 0001425738-18-000024

ALDER BIOPHARMACEUTICALS INC · ALDR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeremy Green
Director
Period of report
Apr 25, 2018
Accepted (ET)
Apr 26, 2018 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2,F3,F1$13.20Apr 25, 2018A30,000A—Apr 25, 2028Common Stock30,00030,000I

Explanation of responses